Trending NewsTrending NewsNYSE:TMO Thermo Fisher Scientific (TMO) Stock Price, News & Analysis $704.74 -12.97 (-1.81%) As of 01:13 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Thermo Fisher Scientific Stock (NYSE:TMO) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get TMO alerts:Sign Up Key Stats Today's Range$696.01▼$711.8650-Day Range$603.43▼$721.9652-Week Range$435.27▼$727.56Volume889,541 shsAverage Volume2.25 million shsMarket Capitalization$261.12 billionP/E Ratio37.17Dividend Yield0.27%Price Target$683.64Consensus RatingModerate Buy Company Overview Thermo Fisher Scientific develops and supplies products and services used in scientific research, clinical diagnostics, and pharmaceutical and biotechnology manufacturing. Its offerings include laboratory instruments, reagents and consumables, analytical equipment, diagnostic tests, and services that support drug development and clinical research. The company operates through businesses focused on life sciences, analytical instruments, specialty diagnostics, and laboratory products and biopharma services. Its brands include Thermo Scientific, Applied Biosystems, Invitrogen, and Fisher Scientific. Thermo Fisher was formed in 2006 through the merger of Thermo Electron and Fisher Scientific, companies with roots in laboratory and scientific equipment. Based in Waltham, Massachusetts, it serves customers around the world. Marc N. Casper is the company’s chairman, president, and chief executive officer.AI Generated. May Contain Errors. Read More Thermo Fisher Scientific Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks74th Percentile Overall ScoreTMO MarketRank™: 3.69277187459 of 5 starsThermo Fisher Scientific scored higher than 74% of companies evaluated by MarketBeat, and ranked 94th out of 892 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.5 / 5Analyst RatingModerate Buy Consensus RatingThermo Fisher Scientific has received a consensus rating of Moderate Buy. The company's average rating score is 2.93, and is based on 2 strong buy ratings, 23 buy ratings, 4 hold ratings, and no sell ratings.Upside/DownsideThe consensus price target for Thermo Fisher Scientific is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageThermo Fisher Scientific has been the subject of 23 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Thermo Fisher Scientific's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth10.13% Earnings GrowthEarnings for Thermo Fisher Scientific are expected to grow by 10.13% in the coming year, from $25.27 to $27.83 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Thermo Fisher Scientific is 37.21, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.60.Price to Earnings Ratio vs. SectorThe P/E ratio of Thermo Fisher Scientific is 37.21, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 35.17.Price to Earnings Growth RatioThermo Fisher Scientific has a PEG Ratio of 2.92. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioThermo Fisher Scientific has a P/B Ratio of 4.77. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.30% of the float of Thermo Fisher Scientific has been sold short.Short Interest Ratio / Days to CoverThermo Fisher Scientific has a short interest ratio ("days to cover") of 1.97, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Thermo Fisher Scientific has recently decreased by 2.11%, indicating that investor sentiment is improving. Dividend2.5 / 5Dividend StrengthModerate Dividend YieldThermo Fisher Scientific has a dividend yield of 0.26%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthThermo Fisher Scientific has been increasing its dividend for 8 years.Dividend CoverageThe dividend payout ratio of Thermo Fisher Scientific is 9.92%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Thermo Fisher Scientific will have a dividend payout ratio of 6.76% next year. This indicates that Thermo Fisher Scientific will be able to sustain or increase its dividend.Read more about Thermo Fisher Scientific's dividend. News and Social Media3.9 / 5News Sentiment1.24 News SentimentThermo Fisher Scientific has a news sentiment score of 1.24. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.58 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 41 news articles for Thermo Fisher Scientific this week, compared to 9 articles on an average week.Search InterestOnly 29 people have searched for TMO on MarketBeat in the last 30 days. This is a decrease of -17% compared to the previous 30 days.MarketBeat Follows9 people have added Thermo Fisher Scientific to their MarketBeat watchlist in the last 30 days. This is an increase of 29% compared to the previous 30 days. Company Ownership1.4 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Thermo Fisher Scientific insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $15,479,192.00 in company stock.Percentage Held by Insiders0.33% of the stock of Thermo Fisher Scientific is held by insiders.Percentage Held by Institutions89.23% of the stock of Thermo Fisher Scientific is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Thermo Fisher Scientific's insider trading history. Receive TMO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Thermo Fisher Scientific and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TMO Stock News HeadlinesSingle-Use Bioprocessing - Global Strategic Business Report 2026: Capitalize on 13.4% CAGR to $47.7B by 2032, Featuring Profiles of Danaher, Thermo Fisher Scientific, 3M, and Eppendorf2 hours ago | finance.yahoo.comCell Lysis / Cell Fractionation - Global Strategic Business Report 2026: Capture the $4.5 Billion Market by 2032 | Features Competitive Intelligence on Thermo Fisher, Beckman Coulter, Bio-Rad, Qiagen and Merck2 hours ago | finance.yahoo.comA free stock pick, from me to youElon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Without its chip, his AI satellites don't fly. Now he wants 1,000,000 of them in orbit, 100 times what's up there today, and every one pays this company a royalty. Dylan believes shares could react by December 8th.November 12 at 1:00 AM | Behind the Markets (Ad)Cell Culture Protein Surface Coating - Global Strategic Business Report 2026: Capitalize on the $2.1B Market by 2032 as Corning, Merck, Sartorius and Thermo Fisher Accelerate Competition2 hours ago | finance.yahoo.comThermo Fisher Scientific (TMO), Why Is It Back In The Spotlight?2 hours ago | finance.yahoo.comEpigenetics - Global Strategic Business Report: Capitalize on an 18.2% CAGR to Secure the $5.5 Billion 2030 Market as Illumina, Thermo Fisher Scientific, Qiagen, and Bio-Rad Disrupt Precision MedicineNovember 11 at 12:49 PM | finance.yahoo.comThermo Fisher Scientific (NYSE:TMO) VP Sells $1,999,959.95 in StockOctober 31, 2026 | insidertrades.comQuantum BioPharma’s Phase 2 Shows Where Biotech Value Actually Gets Built (TMO)Biotech stocks trade on FDA trial phases. Phase 2 data often builds value, cash runway limits dilution, and Quantum BioPharma just began a phase 2 MS trial.October 15, 2026 | marketbeat.comSee More Headlines TMO Stock Analysis - Frequently Asked Questions How have TMO shares performed this year? Thermo Fisher Scientific's stock was trading at $579.42 at the beginning of the year. Since then, TMO stock has increased by 21.7% and is now trading at $705.2240. How were Thermo Fisher Scientific's earnings last quarter? Thermo Fisher Scientific Inc. (NYSE:TMO) posted its quarterly earnings data on Wednesday, October, 21st. The medical research company reported $6.68 EPS for the quarter, beating the consensus estimate of $6.40 by $0.28. Thermo Fisher Scientific's quarterly revenue was up 9.1% on a year-over-year basis. Read the conference call transcript. Is Thermo Fisher Scientific doing a stock buyback? Thermo Fisher Scientific's Board of Directors approved a stock buyback plan on Thursday, November 6th 2025, which authorizes the company to buy back $5 billion in outstanding shares, according to EventVestor. This means that the company could repurchase up to 2.4% of its shares through open market purchases. Shares buyback plans are generally an indication that the company's leadership believes its shares are undervalued. Does Thermo Fisher Scientific have any subsidiaries? Thermo Fisher Scientific subsidiaries include these companies: Henogen, Phinotex, Qiagen, Brammer Bio, HighChem, Gatan Inc, IntegenX, and more. Who are Thermo Fisher Scientific's major shareholders? Top institutional investors of Thermo Fisher Scientific include Sumitomo Mitsui Trust Group Inc. (0.28%), Rathbones Group PLC (0.25%), Pictet Asset Management Holding SA (0.24%) and Voya Investment Management LLC (0.21%). Insiders that own company stock include Marc N Casper, Michel Lagarde, Stephen Williamson, Gianluca Pettiti, Michael D Shafer, Frederick M Lowery, Lisa P Britt, Michael A Boxer, Joseph R Holmes and Debora L Spar. View institutional ownership trends. How do I buy shares of Thermo Fisher Scientific? Shares of TMO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Thermo Fisher Scientific own? Based on aggregate information from My MarketBeat watchlists, some other companies that Thermo Fisher Scientific investors own include NVIDIA (NVDA), Visa (V), Salesforce (CRM), Advanced Micro Devices (AMD), Tesla (TSLA), JPMorgan Chase & Co. (JPM) and Mastercard (MA). Company Calendar Record date for 10/15 Dividend9/15/2026Ex-Dividend for 10/15 Dividend9/15/2026Dividend Payable10/15/2026Last Earnings10/21/2026Today11/12/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (4m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 TMO's financial health is in the Green zone, according to TradeSmith. TMO has been in this zone for over 4 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Life Sciences Tools & Services Sub-IndustryLife Sciences Tools & Services Current SymbolNYSE:TMO CIK97745 Webwww.thermofisher.com Phone(781) 622-1000Fax781-622-1207Employees125,000Year Founded1956Price Target and Rating Average Price Target for Thermo Fisher Scientific$683.64 High Price Target$810.00 Low Price Target$510.00 Potential Upside/Downside-3.0%Consensus RatingModerate Buy Rating Score (0-4)2.93 Research Coverage29 Analysts Profitability EPS (Trailing Twelve Months)$18.96 Trailing P/E Ratio37.19 Forward P/E Ratio25.34 P/E Growth2.92Net Income$6.70 billion Net Margins14.94% Pretax Margin16.68% Return on Equity17.33% Return on Assets8.18% Debt Debt-to-Equity Ratio0.71 Current Ratio1.81 Quick Ratio1.41 Sales & Book Value Annual Sales$47.35 billion Price / Sales5.52 Cash Flow$29.85 per share Price / Cash Flow23.62 Book Value$147.81 per share Price / Book4.77Miscellaneous Outstanding Shares370,516,000Free Float369,293,000Market Cap$261.24 billion OptionableOptionable Beta0.84 Social Links 10 Best Stocks to Own in Fall 2026AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.Get This Free Report This page (NYSE:TMO) was last updated on 11/12/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredYour Social Security check is scheduled for a 22% cutThe U.S. now borrows money just to pay interest on money it already borrowed, a pattern economists call a debt...American Alternative | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredA Bill Would Reprice America's Gold at Market ValueThe US government still values its gold at $42 an ounce, a price Congress set in 1973. Gold trades above $4,00...Concord Gold Capital | SponsoredWatch This NowJensen Huang, the man who launched the AI boom, just called what Elon Musk is chasing "the final frontier of A...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Thermo Fisher Scientific Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Thermo Fisher Scientific With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
